Puma Biotechnology (PBYI) Invested Capital (2017 - 2025)
Historic Invested Capital for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $149.0 million.
- Puma Biotechnology's Invested Capital rose 2797.44% to $149.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $149.0 million, marking a year-over-year increase of 2797.44%. This contributed to the annual value of $137.5 million for FY2024, which is 5719.99% up from last year.
- Latest data reveals that Puma Biotechnology reported Invested Capital of $149.0 million as of Q3 2025, which was up 2797.44% from $138.7 million recorded in Q2 2025.
- In the past 5 years, Puma Biotechnology's Invested Capital ranged from a high of $149.0 million in Q3 2025 and a low of -$10.9 million during Q3 2021
- Moreover, its 5-year median value for Invested Capital was $60.9 million (2021), whereas its average is $65.7 million.
- As far as peak fluctuations go, Puma Biotechnology's Invested Capital plummeted by 30760.31% in 2021, and later soared by 98340.15% in 2022.
- Quarter analysis of 5 years shows Puma Biotechnology's Invested Capital stood at -$2.4 million in 2021, then skyrocketed by 983.4% to $21.6 million in 2022, then soared by 304.66% to $87.4 million in 2023, then soared by 57.2% to $137.5 million in 2024, then increased by 8.39% to $149.0 million in 2025.
- Its Invested Capital was $149.0 million in Q3 2025, compared to $138.7 million in Q2 2025 and $142.4 million in Q1 2025.